Ask what Korea is talking about.

Starting Nov. 12, South Korea will allow individuals to bring up to three months' supply of obesity drugs purchased legally overseas, such as Wegovy and Mounjaro, into the country, the Ministry of Food and Drug Safety and the Korea Customs Service announced on Nov. 11. The move reverses a previous ban on personal carry-in of these treatments, which had been restricted due to concerns over distribution, storage, and legal protections like recalls and compensation, according to Chosun Ilbo. The Korea Times also reported that the ministry issued a safety alert Wednesday over a rare vision-loss risk linked to GLP-1 obesity drugs. Korean media coverage focuses on the policy change itself, with Chosun Ilbo noting the new allowance applies to drugs formally prescribed abroad.